| Elevator Pitch |
The current focus of the company's activities involves the development of pharmaceutical technologies based upon agents which target Leukocyte Function Antigen-1 (LFA-1). |
| Industry Focus |
BioPharma |
| Category |
Companies - Pre-Revenue |
|
|
|
Amount: $500,000
Closed: March 20, 2009
|
|
|
|
|
|
|
Round: Series A
Amount: $500,000 (est.)
Closed: March, 2009
|
|
|
|
| Be the first to recommend Actinobac Biomed Inc.!
Log in |
Public information, member edits, and the DealHorizon.com team.
|
Office Location
Statistics
Search Site
Edit/Update
Followers
Please log in
Note: Once associated with a listing, Executives are automatically included as followers of that listing. Listing
creators are also automatically added as followers.
|
